{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:29:42Z","timestamp":1786350582632,"version":"build-2736575974"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["RD-2020C2-20329"],"award-info":[{"award-number":["RD-2020C2-20329"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1TR004403"],"award-info":[{"award-number":["UM1TR004403"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007345","name":"Cancer Center","doi-asserted-by":"publisher","award":["P30 CA086862"],"award-info":[{"award-number":["P30 CA086862"]}],"id":[{"id":"10.13039\/100007345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neuroendocrine tumors (NETs) are rare, heterogeneous neoplasms associated with prolonged survival and substantial symptom burden. However, patient-reported outcomes across NET subtypes remain poorly characterized, particularly in real-world settings. This study describes baseline health-related quality of life (HRQoL) and care experiences among patients with gastroenteropancreatic and lung NETs, examining differences by tumor site and time since diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Neuroendocrine Tumors\u2013Patient Reported Outcomes study is a prospective, multi-institutional US cohort of adults (aged 18\u2009years and older) with incident small intestinal, pancreatic, gastroenteropancreatic, or lung NETs diagnosed from January 2018 through September 2024, identified via a validated electronic medical record\u2013based computable phenotype. Baseline surveys assessed HRQoL, symptoms, care experiences, and clinical characteristics using validated instruments. Descriptive statistics and standardized mean differences compared responses by NET site and time since diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 2367 participants (mean age = 57.8\u2009years; 57.3% female), 1974 had gastroenteropancreatic NETs (659 small intestinal NET, 555 pancreatic NET) and 393 had lung NETs. Fatigue (mean = 33.0), insomnia (mean = 32.5), and diarrhea (mean = 25.7) were the most burdensome symptoms. Lung NET patients reported worse dyspnea (standardized mean difference =\u202f0.58, P\u202f&amp;lt;\u202f.001) and lower physical, role, and global QoL scores than those with gastroenteropancreatic NETs, while pancreatic NET patients reported better functioning. Diarrhea worsened over time, especially in small intestinal NETs. Most rated care highly (75.3%) but cited concerns about treatment side effects (80.4%), costs (60.7%), and travel burden (58.8%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This large US cohort reveals persistent symptom burden and HRQoL variation by tumor site and disease duration, underscoring the need for longitudinal HRQoL assessment in NET care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djag069","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:31:03Z","timestamp":1772541063000},"page":"1403-1415","source":"Crossref","is-referenced-by-count":0,"title":["Quality of life and care experiences in a US multi-institutional neuroendocrine tumor cohort"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2425-3323","authenticated-orcid":false,"given":"Michael A","family":"O\u2019Rorke","sequence":"first","affiliation":[{"name":"Department of Epidemiology, College of Public Health, University of Iowa , Iowa City, IA,","place":["United States"]},{"name":"Holden Comprehensive Cancer Center, University of Iowa , Iowa City, IA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7568-6598","authenticated-orcid":false,"given":"Tao","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, College of Public Health, University of Iowa , Iowa City, IA,","place":["United States"]},{"name":"Holden Comprehensive Cancer Center, University of Iowa , Iowa City, IA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda R","family":"DeCook","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, College of Public Health, University of Iowa , Iowa City, IA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8802-7686","authenticated-orcid":false,"given":"Bradley D","family":"McDowell","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, College of Public Health, University of Iowa , Iowa City, IA,","place":["United States"]},{"name":"Holden Comprehensive Cancer Center, University of Iowa , Iowa City, IA,","place":["United States"]},{"name":"Population Research Core, Holden Comprehensive Cancer Center, University of Iowa , Iowa City, IA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0928-2943","authenticated-orcid":false,"given":"Brian M","family":"Gryzlak","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, College of Public Health, University of Iowa , Iowa City, IA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1066-8754","authenticated-orcid":false,"given":"Nicholas J","family":"Rudzianski","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, College of Public Health, University of Iowa , Iowa City, IA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0073-4597","authenticated-orcid":false,"given":"Kimberly C","family":"Serrano","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, College of Public Health, University of Iowa , Iowa City, IA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigayle M","family":"Wehrheim","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, College of Public Health, University of Iowa , Iowa City, IA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9638-3629","authenticated-orcid":false,"given":"Udhayvir S","family":"Grewal","sequence":"additional","affiliation":[{"name":"Holden Comprehensive Cancer Center, University of Iowa , Iowa City, IA,","place":["United States"]},{"name":"Department of Internal Medicine, Carver College of Medicine, University of Iowa , Iowa City, IA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrikha","family":"Chandrasekharan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Carver College of Medicine, University of Iowa , Iowa City, IA,","place":["United States"]},{"name":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4002-1418","authenticated-orcid":false,"given":"Joseph S","family":"Dillon","sequence":"additional","affiliation":[{"name":"Holden Comprehensive Cancer Center, University of Iowa , Iowa City, IA,","place":["United States"]},{"name":"Department of Internal Medicine, Carver College of Medicine, University of Iowa , Iowa City, IA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8460-1257","authenticated-orcid":false,"given":"Thorvardur R","family":"Halfdanarson","sequence":"additional","affiliation":[{"name":"Mayo Clinic Medical Oncology, , Rochester, MN,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T Clark","family":"Gamblin","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin Surgical Oncology, , Milwaukee, WI,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay G","family":"Cowell","sequence":"additional","affiliation":[{"name":"O\u2019Donnell School of Public Health, UT Southwestern Medical Center , Dallas, TX,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2262-0011","authenticated-orcid":false,"given":"Tobias","family":"Else","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan , Ann Arbor, MI,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5185-2583","authenticated-orcid":false,"given":"Heloisa P","family":"Soares","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, University of Utah , Salt Lake City, UT,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5878-9900","authenticated-orcid":false,"given":"Vineeth","family":"Sukrithan","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, The Ohio State University Comprehensive Cancer Center , Columbus, OH,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sravani","family":"Chandaka","sequence":"additional","affiliation":[{"name":"University of Kansas Medical Center , Kansas City, KS,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8679-4486","authenticated-orcid":false,"given":"Hanna K","family":"Sanoff","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0782-1170","authenticated-orcid":false,"given":"Fiona C","family":"He","sequence":"additional","affiliation":[{"name":"Allina Health Cancer Institute Hematology Oncology, , Minneapolis, MN,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Geller","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Surgery, Pittsburgh School of Medicine, , Pittsburgh, PA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8762-5852","authenticated-orcid":false,"given":"Robert A","family":"Ramirez","sequence":"additional","affiliation":[{"name":"Department of Surgery, Medical University of South Carolina , Charleston, SC,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8036-2110","authenticated-orcid":false,"given":"Mei","family":"Liu","sequence":"additional","affiliation":[{"name":"NorCal CarciNET Community , Oakland, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Lancaster","sequence":"additional","affiliation":[{"name":"Healing NET Foundation , Los Angeles, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7666-4386","authenticated-orcid":false,"given":"Josh A","family":"Mailman","sequence":"additional","affiliation":[{"name":"Neuroendocrine Cancer Awareness Network , Fort Mill, SC,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7987-1180","authenticated-orcid":false,"given":"Heather","family":"Moran","sequence":"additional","affiliation":[{"name":"Healing NET Foundation , Los Angeles, CA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5499-3093","authenticated-orcid":false,"given":"Maryann","family":"Wahmann","sequence":"additional","affiliation":[{"name":"Neuroendocrine Cancer Awareness Network , Fort Mill, SC,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2160-8875","authenticated-orcid":false,"given":"Elyse","family":"Gellerman","sequence":"additional","affiliation":[{"name":"Neuroendocrine Tumor Research Foundation , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1843-1955","authenticated-orcid":false,"given":"Elizabeth A","family":"Chrischilles","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, College of Public Health, University of Iowa , Iowa City, IA,","place":["United States"]},{"name":"Holden Comprehensive Cancer Center, University of Iowa , Iowa City, IA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the NET-PRO Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanna M","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A","family":"Chrischilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay G","family":"Cowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Cerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Early","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Else","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T Clark","family":"Gamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse","family":"Gellerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Gryzlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorvardur R","family":"Halfdanarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harley C","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona C","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Hourcade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Indrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed M","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amoni Lewis-","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh A","family":"Mailman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"McDowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela L","family":"O\u2019Dell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O\u2019Rorke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H","family":"Ramnaraign","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Roller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna K","family":"Sanoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heloisa P","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineeth","family":"Sukrithan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley W","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia S","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryann","family":"Wahmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin M","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon K D","family":"Zamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"2026081003531973500_djag069-B1","doi-asserted-by":"crossref","first-page":"19245","DOI":"10.18632\/oncotarget.24983","article-title":"Global burden of neuroendocrine tumors and changing incidence in Kentucky","volume":"9","author":"Chauhan","year":"2018","journal-title":"Oncotarget"},{"key":"2026081003531973500_djag069-B2","doi-asserted-by":"crossref","first-page":"e70001","DOI":"10.1111\/jne.70001","article-title":"Incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): an updated systematic review of population-based reports from 2010 to 2023","volume":"37","author":"Nordstrand","year":"2025","journal-title":"J Neuroendocrinol"},{"key":"2026081003531973500_djag069-B3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/17446651.2023.2237593","article-title":"Understanding the increasing incidence of neuroendocrine tumors","volume":"18","author":"Pathak","year":"2023","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2026081003531973500_djag069-B4","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1097\/sla.0000000000006331","article-title":"Charting the course: insights into neuroendocrine tumor dynamics in the United States","volume":"281","author":"Wu","year":"2025","journal-title":"Ann Surg"},{"key":"2026081003531973500_djag069-B5","doi-asserted-by":"crossref","first-page":"e13264","DOI":"10.1111\/jne.13264","article-title":"Incidence and prevalence of neuroendocrine neoplasms in Norway 1993-2021","volume":"35","author":"Thiis-Evensen","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"2026081003531973500_djag069-B6","doi-asserted-by":"crossref","first-page":"100510","DOI":"10.1016\/j.lanepe.2022.100510","article-title":"Incidence and survival of neuroendocrine neoplasia in England 1995-2018: a retrospective, population-based study","volume":"23","author":"White","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2026081003531973500_djag069-B7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JGO.2015.002980","article-title":"Patient-reported burden of a neuroendocrine tumor (NET) diagnosis: results from the first global survey of patients with NETs","volume":"3","author":"Singh","year":"2017","journal-title":"J Glob Oncol"},{"key":"2026081003531973500_djag069-B8","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1186\/s12885-019-6412-8","article-title":"Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources","volume":"19","author":"Darb\u00e0","year":"2019","journal-title":"BMC Cancer"},{"key":"2026081003531973500_djag069-B9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"key":"2026081003531973500_djag069-B10","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1002\/ijc.30400","article-title":"The epidemiology of metastases in neuroendocrine tumors","volume":"139","author":"Riihim\u00e4ki","year":"2016","journal-title":"Int J Cancer"},{"key":"2026081003531973500_djag069-B11","doi-asserted-by":"crossref","first-page":"100105","DOI":"10.1016\/j.soi.2024.100105","article-title":"Real-world analysis of neuroendocrine tumor misdiagnosis and associated costs","volume":"1","author":"Clarke","year":"2024","journal-title":"Surg Oncol Insight"},{"key":"2026081003531973500_djag069-B12","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1159\/000513249","article-title":"Unique metastatic patterns in neuroendocrine neoplasms of different primary origin","volume":"111","author":"Hermans","year":"2021","journal-title":"Neuroendocrinology"},{"key":"2026081003531973500_djag069-B13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(17)30110-9","article-title":"Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study","volume":"18","author":"Halperin","year":"2017","journal-title":"Lancet Oncol"},{"key":"2026081003531973500_djag069-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.19.00025","article-title":"Living with neuroendocrine tumors: assessment of quality of life through a mobile application","volume":"3","author":"Adams","year":"2019","journal-title":"JCO Clin Cancer Inform"},{"key":"2026081003531973500_djag069-B15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neo.2017.09.002","article-title":"Nothing but NET: a review of neuroendocrine tumors and carcinomas","volume":"19","author":"Oronsky","year":"2017","journal-title":"Neoplasia"},{"key":"2026081003531973500_djag069-B16","first-page":"1330","article-title":"Patient-defined goals and preferences among adults with advanced neuroendocrine tumors","volume":"20","author":"Li","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"2026081003531973500_djag069-B17","first-page":"278","article-title":"Patient-reported outcomes in cancer: a review of recent research and policy initiatives","volume":"57","author":"Lipscomb","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"2026081003531973500_djag069-B18","doi-asserted-by":"crossref","first-page":"dju244","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2026081003531973500_djag069-B19","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1002\/cncr.32959","article-title":"Incorporating patient preferences into cancer care decisions: challenges and opportunities","volume":"126","author":"Veenstra","year":"2020","journal-title":"Cancer"},{"key":"2026081003531973500_djag069-B20","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/pon.5750","article-title":"Patients\u2019 preferred and perceived level of involvement in decision making for cancer treatment: a systematic review","volume":"30","author":"Noteboom","year":"2021","journal-title":"Psychooncology"},{"key":"2026081003531973500_djag069-B21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaoncol.2014.112","article-title":"Association of actual and preferred decision roles with patient-reported quality of care: shared decision making in cancer care","volume":"1","author":"Kehl","year":"2015","journal-title":"JAMA Oncol"},{"key":"2026081003531973500_djag069-B22","first-page":"387","volume-title":"Cancers","author":"Padilla","year":"2025"},{"key":"2026081003531973500_djag069-B23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s41687-021-00336-8","article-title":"Measuring health-related quality of life in patients with rare disease","volume":"5","author":"Lenderking","year":"2021","journal-title":"J Patient Rep Outcomes"},{"key":"2026081003531973500_djag069-B24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12955-016-0527-2","article-title":"Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours","volume":"14","author":"Martini","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"2026081003531973500_djag069-B25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10555-015-9573-1","article-title":"Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors","volume":"34","author":"Jim\u00e9nez-Fonseca","year":"2015","journal-title":"Cancer Metastasis Rev"},{"key":"2026081003531973500_djag069-B26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MPA.0b013e3182328045","article-title":"Comparison of health-related quality of life in patients with neuroendocrine tumors with quality of life in the general US population","volume":"41","author":"Beaumont","year":"2012","journal-title":"Pancreas"},{"key":"2026081003531973500_djag069-B27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s11136-009-9487-x","article-title":"Health related quality of life in patients with neuroendocrine tumors compared with the general Norwegian population","volume":"18","author":"Haugland","year":"2009","journal-title":"Qual Life Res"},{"key":"2026081003531973500_djag069-B28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000497330","article-title":"Observational study to assess quality of life in patients with pancreatic neuroendocrine tumors receiving treatment with Everolimus: the OBLIQUE Study (UK Phase IV Trial)","volume":"108","author":"Ramage","year":"2019","journal-title":"Neuroendocrinology"},{"key":"2026081003531973500_djag069-B29","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/ijc.32678","article-title":"Unmet needs in the international neuroendocrine tumor (NET) community: assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals","volume":"146","author":"Leyden","year":"2020","journal-title":"Int J Cancer"},{"key":"2026081003531973500_djag069-B30","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1634\/theoncologist.2019-0112","article-title":"Patterns of symptoms burden in neuroendocrine tumors: a population-based analysis of prospective patient-reported outcomes","volume":"24","author":"Hallet","year":"2019","journal-title":"Oncologist"},{"key":"2026081003531973500_djag069-B31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/MPA.0000000000000818","article-title":"Patient-reported experience of diagnosis, management, and burden of neuroendocrine tumors: results from a large patient survey in the United States","volume":"46","author":"Wolin","year":"2017","journal-title":"Pancreas"},{"key":"2026081003531973500_djag069-B32","first-page":"577","article-title":"The unmet information needs, quality of life, and care experiences of patients with neuroendocrine tumours (NETs) at follow-up: 6 months from diagnosis","volume":"31","author":"Guccione","year":"2023","journal-title":"Support Care Cancer"},{"key":"2026081003531973500_djag069-B33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/oncolo\/oyad312","article-title":"Patient priorities concerning treatment decisions for advanced neuroendocrine tumors identified by discrete choice experiments","volume":"29","author":"Anaka","year":"2024","journal-title":"Oncologist"},{"key":"2026081003531973500_djag069-B34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N Engl J Med"},{"key":"2026081003531973500_djag069-B35","doi-asserted-by":"crossref","first-page":"e68788","DOI":"10.2196\/68788","article-title":"Personal health record software for neuroendocrine tumors: patient-centered design approach","volume":"12","author":"Hourcade","year":"2025","journal-title":"JMIR Hum Factors"},{"key":"2026081003531973500_djag069-B36","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/cncr.35184","article-title":"Making progress against rare cancers: a case study on neuroendocrine tumors","volume":"130","author":"O\u2019Rorke","year":"2024","journal-title":"Cancer"},{"key":"2026081003531973500_djag069-B37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejca.2005.10.025","article-title":"Development of a disease-specific Quality of Life questionnaire module for patients with gastrointestinal neuroendocrine tumours","volume":"42","author":"Davies","year":"2006","journal-title":"Eur J Cancer"},{"key":"2026081003531973500_djag069-B38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/bjc.2012.560","article-title":"Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours","volume":"108","author":"Yadegarfar","year":"2013","journal-title":"Br J Cancer"},{"key":"2026081003531973500_djag069-B39","doi-asserted-by":"crossref","first-page":"e87\u201395","DOI":"10.1097\/MPA.0b013e31819b6441","article-title":"Development of the Norfolk quality of life tool for assessing patients with neuroendocrine tumors","volume":"38","author":"Vinik","year":"2009","journal-title":"Pancreas"},{"key":"2026081003531973500_djag069-B40","doi-asserted-by":"crossref","first-page":"Ms22","DOI":"10.1097\/00005650-199903001-00003","article-title":"Psychometric properties of the CAHPS 1.0 survey measures. Consumer assessment of health plans study","volume":"37","author":"Hays","year":"1999","journal-title":"Med Care"},{"key":"2026081003531973500_djag069-B41","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1200\/JCO.2009.27.3268","article-title":"Patients\u2019 experiences with care for lung cancer and colorectal cancer: findings from the cancer care outcomes research and surveillance consortium","volume":"28","author":"Ayanian","year":"2010","journal-title":"J Clin Oncol"},{"key":"2026081003531973500_djag069-B42","first-page":"837","article-title":"Understanding cancer patients\u2019 experience and outcomes: development and pilot study of the cancer care outcomes research and surveillance patient survey","volume":"14","author":"Malin","year":"2006","journal-title":"Support Care Cancer"},{"key":"2026081003531973500_djag069-B43"},{"key":"2026081003531973500_djag069-B44","doi-asserted-by":"crossref","DOI":"10.4324\/9780203771587","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"2013"},{"key":"2026081003531973500_djag069-B45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12955-019-1220-z","article-title":"The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis","volume":"17","author":"Rivera","year":"2019","journal-title":"Health Qual Life Outcomes"},{"key":"2026081003531973500_djag069-B46","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/PPO.0b013e31822c28b3","article-title":"Electronic toxicity monitoring and patient-reported outcomes","volume":"17","author":"Basch","year":"2011","journal-title":"Cancer J"},{"key":"2026081003531973500_djag069-B47","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/jnci\/djp386","article-title":"Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes","volume":"101","author":"Basch","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"2026081003531973500_djag069-B48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J Clin Oncol"},{"key":"2026081003531973500_djag069-B49","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.3390\/cancers14061428","article-title":"Health-Related Quality of Life (HRQoL) in neuroendocrine tumors: a systematic review","volume":"14","author":"Gosain","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026081003531973500_djag069-B50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1740774515615540","article-title":"Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial","volume":"13","author":"Basch","year":"2016","journal-title":"Clin Trials"},{"key":"2026081003531973500_djag069-B51","first-page":"1169","article-title":"Integrating patient-reported outcome measures into routine cancer care: cancer patients\u2019 and clinicians\u2019 perceptions of acceptability and value","volume":"3","author":"Stover","year":"2015","journal-title":"EGEMS (Wash DC)"},{"key":"2026081003531973500_djag069-B52","doi-asserted-by":"crossref","first-page":"R267","DOI":"10.1530\/ERC-20-0066","article-title":"Health-related quality of life in neuroendocrine neoplasia: a critical review","volume":"27","author":"White","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"2026081003531973500_djag069-B53","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1007\/s40618-022-01872-w","article-title":"Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study","volume":"45","author":"Modica","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"2026081003531973500_djag069-B54","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3748\/wjg.v24.i6.671","article-title":"Health-related quality of life, anxiety, depression and impulsivity in patients with advanced gastroenteropancreatic neuroendocrine tumours","volume":"24","author":"Lewis","year":"2018","journal-title":"World J Gastroenterol"},{"key":"2026081003531973500_djag069-B55","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1200\/JCO.2018.78.5865","article-title":"Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with (177)Lu-DOTATATE in the phase III NETTER-1 trial","volume":"36","author":"Strosberg","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026081003531973500_djag069-B56","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1007\/s00259-021-05332-0","article-title":"177)Lu-DOTATATE in older patients with metastatic neuroendocrine tumours: safety, efficacy and health-related quality of life","volume":"48","author":"Chen","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026081003531973500_djag069-B57","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1097\/NCC.0000000000000614","article-title":"Symptoms, psychosocial factors, and health-related quality of life in patients with neuroendocrine tumors: an integrative review","volume":"42","author":"Haugland","year":"2019","journal-title":"Cancer Nurs"},{"key":"2026081003531973500_djag069-B58","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s40273-021-01071-0","article-title":"A systematic review of economic and quality-of-life research in carcinoid syndrome","volume":"39","author":"Pan","year":"2021","journal-title":"Pharmacoeconomics"},{"key":"2026081003531973500_djag069-B59","doi-asserted-by":"crossref","first-page":"114030","DOI":"10.1016\/j.ejca.2024.114030","article-title":"EORTC QLQ-C30 general population normative data for the United States","volume":"202","author":"Rogge","year":"2024","journal-title":"Eur J Cancer"},{"key":"2026081003531973500_djag069-B60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2018.11.024","article-title":"General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States","volume":"107","author":"Nolte","year":"2019","journal-title":"Eur J Cancer"},{"key":"2026081003531973500_djag069-B61","doi-asserted-by":"crossref","first-page":"103153","DOI":"10.1016\/j.eclinm.2025.103153","article-title":"Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation study","volume":"82","author":"Lim","year":"2025","journal-title":"EClinicalMedicine"},{"key":"2026081003531973500_djag069-B62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1200\/op-25-00133:Op2500133","article-title":"Symptom management for well-differentiated Gastroenteropancreatic neuroendocrine tumors: ASCO guideline","volume":"22","author":"Perez","year":"2026","journal-title":"JCO Oncol Pract"},{"key":"2026081003531973500_djag069-B63","doi-asserted-by":"crossref","first-page":"953886","DOI":"10.3389\/fpubh.2022.953886","article-title":"Prevalence of multimorbidity combinations and their association with medical costs and poor health: a population-based study of U.S. adults","volume":"10","author":"Schiltz","year":"2022","journal-title":"Front Public Health"},{"key":"2026081003531973500_djag069-B64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","article-title":"Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies","volume":"12","author":"Mitchell","year":"2011","journal-title":"Lancet Oncol"},{"key":"2026081003531973500_djag069-B65","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkaa123","article-title":"Factors associated with health-related quality of life among cancer survivors in the United States","volume":"5","author":"Han","year":"2021","journal-title":"JNCI Cancer Spectr"},{"key":"2026081003531973500_djag069-B66","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.5888\/pcd22.240539","article-title":"Trends in multiple chronic conditions among US adults, by life stage, behavioral risk factor surveillance system, 2013-2023","volume":"22","author":"Watson","year":"2025","journal-title":"Prev Chronic Dis"},{"key":"2026081003531973500_djag069-B67","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jss.2015.05.048","article-title":"Quality of life after treatment of neuroendocrine liver metastasis","volume":"198","author":"Spolverato","year":"2015","journal-title":"J Surg Res"},{"key":"2026081003531973500_djag069-B68","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1210\/clinem\/dgaa760","article-title":"Quality of life in patients with Neuroendocrine neoplasms: the role of severity, clinical heterogeneity, and resilience","volume":"106","author":"Scandurra","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026081003531973500_djag069-B69","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S1470-2045(17)30471-0","article-title":"Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"18","author":"Pavel","year":"2017","journal-title":"Lancet Oncol"},{"key":"2026081003531973500_djag069-B70","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1007\/s00268-022-06479-z","article-title":"Anxiety, depression and quality of life in patients with neuroendocrine neoplasia after surgery","volume":"46","author":"Begum","year":"2022","journal-title":"World J Surg"},{"key":"2026081003531973500_djag069-B71","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/14737140.2023.2207829","article-title":"Consideration of quality of life in the treatment decision-making for patients with advanced gastroenteropancreatic neuroendocrine tumors","volume":"23","author":"Naraev","year":"2023","journal-title":"Expert Rev Anticancer Ther"},{"key":"2026081003531973500_djag069-B72","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.3748\/wjg.v26.i25.3686","article-title":"Quality of life in patients with gastroenteropancreatic tumours: a systematic literature review","volume":"26","author":"Watson","year":"2020","journal-title":"World J Gastroenterol"},{"key":"2026081003531973500_djag069-B73","doi-asserted-by":"crossref","first-page":"e13097","DOI":"10.1111\/jne.13097","article-title":"Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module)","volume":"34","author":"Ramage","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"2026081003531973500_djag069-B74","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/cen.14336","article-title":"Long-term health-related quality of life in persons diagnosed with an insulinoma in Finland 1980-2010","volume":"94","author":"Peltola","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026081003531973500_djag069-B75","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/oxfordjournals.aje.a009487","article-title":"Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries","volume":"147","author":"Bergmann","year":"1998","journal-title":"Am J Epidemiol"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag069\/67295407\/djag069.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/8\/1403\/67295407\/djag069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/8\/1403\/67295407\/djag069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T07:53:37Z","timestamp":1786348417000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/118\/8\/1403\/8513623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":75,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,3,10]]},"published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djag069","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,3,10]]}}}